Latest research report, titled“Global Insights 2022 and Forecast 2028, This includes overview and deep study of factors which are considered to have greater influence over future course of the market ...
Beam Therapeutics Inc. (BEAM) shares ended the last trading session 12.6% higher at $16.37. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback